Sort:
Date
Filter:
All

3,647 result(s) found

Novo Nordisk says Ozempic a 'very likely' target in next Medicare drug pricing talks https://seekingalpha.com/news/4150413-novo-nordisk-ozempic-targeted-medicare-pricing-talks?source=feed_sector_healthcare Sep 17, 2024 - Novo Nordisk's (NVO) diabetes therapy Ozempic may be up for next Medicare drug pricing negotiations, a top company executive said. Read more here.
VNQI: International REITs May Play Catch-Up To U.S. Peers https://seekingalpha.com/article/4721612-vnqi-international-reits-may-play-catch-up-to-us-peers?source=feed_tag_etf_portfolio_strategy Sep 17, 2024 -
DAVIDsTEA Inc. (DTEAF) Q2 2024 Earnings Call Transcript https://seekingalpha.com/article/4721594-davidstea-inc-dteaf-q2-2024-earnings-call-transcript?source=feed_sector_transcripts Sep 17, 2024 - DAVIDsTEA Inc. reported strong Q2 2024 earnings with sales up
Hoth Therapeutics Reports Encouraging Pre-clinical Data For Its Alzheimer's Drug; Stock Up https://www.rttnews.com/story.aspx?Id=3475617 Sep 17, 2024 - Hoth Therapeutics, Inc. (HOTH) Tuesday announced promising preclinical results for its investigational Alzheimer's drug, HT-ALZ. The company's shares were rising more than 15 percent in pre-market.
Billionaire Jeff Bezos Races Rocket Lab and a Chinese Start-Up to Build the Next SpaceX https://www.fool.com/investing/2024/09/17/billionaire-jeff-bezos-races-rocket-lab-and-a/?source=iedfolrf0000001 Sep 17, 2024 - SpaceX has a monopoly on reusable rockets right now, but within a year it could have competition.
Cathie Wood Is Selling The Trade Desk. Should You? https://www.fool.com/investing/2024/09/17/cathie-wood-is-selling-the-trade-desk-should-you/?source=iedfolrf0000001 Sep 17, 2024 - Is the adtech stock's run-up over?
Dan Ives Predicts an Apple "Supercycle" With the New AI-Optimized iPhone. What Could This Mean for the Stock? https://www.fool.com/investing/2024/09/16/dan-ives-predicts-an-apple-supercycle-with-the-new/?source=iedfolrf0000001 Sep 16, 2024 - In the pundit's view, the technology will inspire swarms of users to snap up the company's new smartphone line.
CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data https://seekingalpha.com/news/4150038-cg-oncology-surges-7-seen-benefitting-from-johnson-johnson-bladder-cancer-asset-data?source=feed_sector_healthcare Sep 16, 2024 - CG Oncology stock is up 7% following bladder cancer data released by Johnson & Johnson. Read more here.
Bristol unveils 10-year Opdivo + Yervoy follow-up data in melanoma https://seekingalpha.com/news/4150032-bristol-unveils-10-year-opdivo-yervoy-follow-up-data-melanoma?source=feed_sector_healthcare Sep 16, 2024 - Bristol-Myers Squibb's Opdivo + Yervoy combo shows durable improvement in advanced melanoma over 10 years. Read more here.
How Much Will American Electric Power Pay Out in Dividends This Year? https://www.fool.com/investing/2024/09/16/how-much-will-pay-out-in-dividends-this-year/?source=iedfolrf0000001 Sep 16, 2024 - For income investors, this electric utility is worth getting amped up about.

Pages: 1...6667686970717273747576...365

<<<Page 71>